A citation-based method for searching scientific literature

D L Browne, S T Gancher, J G Nutt, E R Brunt, E A Smith, P Kramer, M Litt. Nat Genet 1994
Times Cited: 577



Steffen Syrbe, Ulrike B S Hedrich, Erik Riesch, Tania Djémié, Stephan Müller, Rikke S Møller, Bridget Maher, Laura Hernandez-Hernandez, Matthis Synofzik, Hande S Caglayan, Mutluay Arslan, José M Serratosa, Michael Nothnagel, Patrick May, Roland Krause, Heidrun Löffler, Katja Detert, Thomas Dorn, Heinrich Vogt, Günter Krämer, Ludger Schöls, Primus E Mullis, Tarja Linnankivi, Anna-Elina Lehesjoki, Katalin Sterbova, Dana C Craiu, Dorota Hoffman-Zacharska, Christian M Korff, Yvonne G Weber, Maja Steinlin, Sabina Gallati, Astrid Bertsche, Matthias K Bernhard, Andreas Merkenschlager, Wieland Kiess, Michael Gonzalez, Stephan Züchner, Aarno Palotie, Arvid Suls, Peter De Jonghe, Ingo Helbig, Saskia Biskup, Markus Wolff, Snezana Maljevic, Rebecca Schüle, Sanjay M Sisodiya, Sarah Weckhuysen, Holger Lerche, Johannes R Lemke. Nat Genet 2015
Times Cited: 142




List of shared articles



Times cited

Paroxysmal Genetic Movement Disorders and Epilepsy.
Claudio M de Gusmão, Lucas Garcia, Mohamad A Mikati, Samantha Su, Laura Silveira-Moriyama. Front Neurol 2021
2


Structural basis of the potency and selectivity of Urotoxin, a potent Kv1 blocker from scorpion venom.
Karen Luna-Ramirez, Agota Csoti, Jeffrey R McArthur, Yanni K Y Chin, Raveendra Anangi, Rosby Del Carmen Najera, Lourival D Possani, Glenn F King, Gyorgy Panyi, Haibo Yu,[...]. Biochem Pharmacol 2020
5

Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
Rían W Manville, Geoffrey W Abbott. J Pharmacol Exp Ther 2020
6

Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.
Kelsey Paulhus, Lauren Ammerman, Edward Glasscock. Int J Mol Sci 2020
15

Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.
Maria Cristina D'Adamo, Antonella Liantonio, Jean-Francois Rolland, Mauro Pessia, Paola Imbrici. Int J Mol Sci 2020
13


Venom-derived modulators of epilepsy-related ion channels.
Chun Yuen Chow, Nathan Absalom, Kimberley Biggs, Glenn F King, Linlin Ma. Biochem Pharmacol 2020
1

Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.
Julia Oyrer, Snezana Maljevic, Ingrid E Scheffer, Samuel F Berkovic, Steven Petrou, Christopher A Reid. Pharmacol Rev 2018
75

De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants.
Amanda Rogers, Paul Golumbek, Elena Cellini, Viola Doccini, Renzo Guerrini, Carina Wallgren-Pettersson, Ann-Charlotte Thuresson, Christina A Gurnett. Am J Med Genet A 2018
17

Venom-derived peptide inhibitors of voltage-gated potassium channels.
Raymond S Norton, K George Chandy. Neuropharmacology 2017
45

Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes.
Elena Parrini, Carla Marini, Davide Mei, Anna Galuppi, Elena Cellini, Daniela Pucatti, Laura Chiti, Domenico Rutigliano, Claudia Bianchini, Simona Virdò,[...]. Hum Mutat 2017
87

Potassium Channels and Human Epileptic Phenotypes: An Updated Overview.
Chiara Villa, Romina Combi. Front Cell Neurosci 2016
57

KCNA4 deficiency leads to a syndrome of abnormal striatum, congenital cataract and intellectual disability.
Namik Kaya, Maysoon Alsagob, Maria Cristina D'Adamo, Albandary Al-Bakheet, Sonia Hasan, Maria Muccioli, Faten B Almutairi, Rawan Almass, Mazhor Aldosary, Dorota Monies,[...]. J Med Genet 2016
11

Pore size matters for potassium channel conductance.
David Naranjo, Hans Moldenhauer, Matías Pincuntureo, Ignacio Díaz-Franulic. J Gen Physiol 2016
13

Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
Mark A Corbett, Susannah T Bellows, Melody Li, Renée Carroll, Silvana Micallef, Gemma L Carvill, Candace T Myers, Katherine B Howell, Snezana Maljevic, Holger Lerche,[...]. Neurology 2016
41